Cwt97126@126.com
July 1997 – July 2001
Bachelor’s Degree: Changchun University of Chinese Medicine, Major in Traditional Chinese Medicine
September 2002 – July 2005
Master’s Degree: Changchun University of Chinese Medicine, Major in Natural Products
September 2005 – May 2009
Doctoral Degree: Chonnam National University, South Korea, Major in Pharmacy
May 2009 – October 2010
Assistant Researcher, Wenzhou Medical University
October 2010 – December 2015
Associate Researcher, Wenzhou Medical University
December 2015 – Present
Researcher, Wenzhou Medical University
December 2024 – Present
Associate Dean, School of Pharmacy, Wenzhou Medical University
Researcher Cong Weitao and his team have long been dedicated to investigating key scientific issues in the fields of cardiovascular and liver diseases. They have conducted innovative research on myocardial infarction injury repair, the pathogenesis of diabetic cardiomyopathy, treatment of myocardial hypertrophy, liver fibrosis, and liver regeneration.
(1) Growth factors and cardiovascular diseases (diabetic cardiomyopathy, myocardial aging, myocardial autophagy, etc.);
(2) Growth factors and liver diseases (hepatic ischemia-reperfusion injury, liver fibrosis, etc.).
1. Second Prize of Scientific Research Achievement, Universities in Zhejiang Province (2/5), 2011.
2. First Prize of Science and Technology Progress, Wenzhou City (3/9), 2012.
3. Selected Candidate for Wenzhou "580 Overseas Elite Introduction Program," 2012.
4. Second Prize of Science and Technology Progress, Zhejiang Province (2/9), 2013.
5. Selected Talent for Zhejiang Qianjiang Talent Program, 2013.
6. Selected Talent for Zhejiang "151" Talent Program, 2015.
7. First Tier Talent of Wenzhou 551 Talent Program, 2016.
8. Selected Candidate for Zhejiang "Medical Rising Star," 2017.
12. Selected Mid-to-Young Age Discipline Leader of Universities in Zhejiang Province, 2017.
13. Selected Leading Talent for Science and Technology Innovation, Wenzhou City, 2018.
14. Youth Top-Talent of Zhejiang "Ten-Thousand Talents Plan," 2019.
15. Innovation Leading Talent of Universities in Zhejiang Province, 2020.
1. Principal Investigator of the National Natural Science Foundation of China (NSFC) General Program: "Mechanistic Study of FGF13 as a Bridging Molecule Mediating RACK1-Promoted HIF-1α Degradation in Regulating Angiogenesis in Lower Limb Ischemia," Project No.: 82570502, Duration: January 2026 – December 2029.
2. Functional and Mechanistic Study of DCAF13 in Alleviating Myocardial Ischemia-Reperfusion Injury via Mediating Proteasomal Degradation of TFR1, Project No.: 82370297, Duration: January 2024 – December 2027.
3. Principal Investigator of NSFC General Program: "Mechanistic Study of FOXO4 Thiol S-Nitrosylation Modification Regulating the Interconversion between Cellular Senescence and Apoptosis Signaling and Its Application in Aging-Related Cardiovascular Diseases," Project No.: 82070507, Duration: January 2021 – December 2024.
4. Principal Investigator of NSFC General Program: "Mechanistic Study of FGF21 Inhibiting High Glucose-Induced Autophagy via the Sirt1-FoxO1 Pathway to Delay Vascular Endothelial Cell Senescence," Project No.: 81770498, Duration: January 2018 – December 2021.
5. Principal Investigator of NSFC General Program: "Regulatory Mechanism of Metallothioneins on Nitrative Damage of α-Ketoglutarate Dehydrogenase in Aging Myocardium," Project No.: 81570368, Duration: January 2016 – December 2019.
6. Principal Investigator of NSFC Young Scientist Fund: "Regulatory Role of Metallothioneins on Nitrative Stress of ATP Synthase in Diabetic Myocardium," Project No.: 81300171, Duration: January 2014 – December 2016.
1. Gen Chen, Ning An, Jinling Shen, Yunjie Chen, Jia Sun, Zhicheng Hu, Lin Mei,
Yanru Sui, Shengqu He, Cheng Jin, Wanqian Li, Huinan Chen, Peng Chen,
Xueqiang Guan, Maoping Chu, Yang Wang, Xiaokun Li, Litai Jin, Kwonseop Kim,
Weitao Cong*, Xu Wang*. Fibroblast growth factor 18 protects against pathological
cardiac hypertrophy. Nature Communication, 2023;14:1235 （共同通讯作者）
2. Junjie Zhu, Zhouxiang Jin, Jie Wang, Zhaohang Wu, Tianpeng Xu, Gaozan
Tong, Enzhao Shen, Junfu Fan, Chunhui Jiang, Jiaqi Wang, Xiaokun Li*, Weitao
Cong*, Li Lin*. FGF21 ameliorates septic liver injury by restraining
proinflammatory macrophages activation through the autophagy/HIF-1α axis.
Journal of Advance Research, 2024, 9:S2090-1232(24)00134-6（共同通讯作者）
3. Nan Wang, Xiejun Xu, Fangqian Guan, Yifan Lin, Yizhou Ye, Jie Zhou, Jianjun
Feng, Sihang Li, Junbo Ye, Zhouhao Tang, Wenjie Gao, Bohao Sun, Yingjie Shen, Li
Sun, Yonghuan Song, Litai Jin, Xiaokun Li*, Weitao Cong*, Zhongxin Zhu*. FGF12
Positively Regulates Keratinocyte Proliferation by Stabilizing MDM2 and Inhibiting
p53 Activity in Psoriasis. Advanced Science, 2024, 5: e2400107（共同通讯作者）
4. Enzhao Shen, Yuecheng Wu, Weijian Ye, Sihang Li, Junjie Zhu, Meifan
Jiang, Zhicheng Hu, Gaoyong Cao, Xiaojing Yi, Fan Li, Zhouhao Tang, Xiaokun
Li, Kwang Youl Lee, Litai Jin*, Xu Wang*, Weitao Cong*. The FGF13‐Caveolin‐1
Axis: A Key Player in the Pathogenesis of Doxorubicin‐ and D‐Galactose‐Induced
Premature Cardiac Aging, Advanced Science, 2025, 12(25): 2501055（通讯作者）
5. Xiang Huang, Junfu Fan, Kunxuan Zhu, Xiangjun Wu, Chunhui Jiang, Junhao
Chen, Jiebin Qiu, Lian Duan, Zhicheng Hu, Xixi Chen, Bin Zhou, Jingling
Shen*, Weitao Cong*. DTL dose-dependent control of sex-dimorphic ferroptosis in
liver ischemia reperfusion injury, Cell Reports（通讯作者）, 2025, 44: 115920.
6. Gaozan Tong , Yiming Chen , Xixi Chen , Junfu Fan, Kunxuan Zhu, ZiJing
Hu, Santie Li, Junjie Zhu, Jianjun Feng, Zhaohang Wu, Zhenyu Hu, Bin Zhou, Litai
Jin, Hui Chen, Jingling Shen, Weitao Cong* , XiaoKun Li*. FGF18 alleviates
hepatic ischemia-reperfusion injury via the USP16-mediated KEAP1/Nrf2 signaling
pathway in male mice. Nature Communication, 2023;14:6107. （共同通讯作者）
7. Jia Sun, Xueqiang Guan, Chao Niu, Peng Chen, Yuankuan Li, Xuejiao Wang, Lan
Luo, Mengxue Liu, Yanni Shou, Xiaozhong Huang, Yan Cai, Junjie Zhu, Junfu Fan,
Xiaokun Li, Litai Jin, Weitao Cong. FGF13-sensitive alteration of Parkin safeguards
mitochondrial homeostasis in endothelium of diabetic nephropathy. Diabetes, 2022,
2023, 72, 97-111 （通讯作者）
8. Santie Li, Bin Zhou, Mei Xue, Junjie Zhu, Gaozan Tong, Junfu Fan, Kunxuan Zhu,
Zijing Hu, Rui Chen, Yonggan Dong, Yiming Chen, Kwang Youl Lee, Xiaokun Li,
Litai Jin, Weitao Cong. Fibroblast growth factor 12 promotes liver fibrosis via
mediating the crosstalk between macrophages and hepatic stellate cells, Hepatology,
2023, 77, 816-833 （通讯作者）
